1. Home
  2. SCVL vs CTNM Comparison

SCVL vs CTNM Comparison

Compare SCVL & CTNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shoe Carnival Inc.

SCVL

Shoe Carnival Inc.

HOLD

Current Price

$18.01

Market Cap

491.1M

ML Signal

HOLD

Logo Contineum Therapeutics Inc.

CTNM

Contineum Therapeutics Inc.

HOLD

Current Price

$13.46

Market Cap

480.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCVL
CTNM
Founded
1978
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
491.1M
480.5M
IPO Year
1994
2024

Fundamental Metrics

Financial Performance
Metric
SCVL
CTNM
Price
$18.01
$13.46
Analyst Decision
Hold
Buy
Analyst Count
1
4
Target Price
N/A
$19.00
AVG Volume (30 Days)
513.7K
281.8K
Earning Date
05-29-2026
05-13-2026
Dividend Yield
3.81%
N/A
EPS Growth
N/A
0.46
EPS
1.90
N/A
Revenue
$1,135,324,000.00
N/A
Revenue This Year
$1.64
N/A
Revenue Next Year
$2.51
N/A
P/E Ratio
$9.40
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.04
$3.35
52 Week High
$26.54
$16.33

Technical Indicators

Market Signals
Indicator
SCVL
CTNM
Relative Strength Index (RSI) 54.81 48.12
Support Level $16.80 $10.17
Resistance Level $18.37 $13.18
Average True Range (ATR) 0.88 0.80
MACD 0.30 0.04
Stochastic Oscillator 95.25 42.79

Price Performance

Historical Comparison
SCVL
CTNM

About SCVL Shoe Carnival Inc.

Shoe Carnival Inc is a family footwear retailer that offers a broad assortment of dress, casual, and athletic footwear for men, women, and children with an emphasis on national name brands such as Nike, Skechers, Adidas, Puma, HEYDUDE, Converse, Vans, and Crocs. The company operates its business as one reportable segment based on the similar nature of products sold; merchandising, distribution, and marketing processes involved; target customers; and economic characteristics of stores and e-commerce platforms. Its bricks-first, omnichannel approach provides customers easy access to a wide assortment of branded footwear for work, athletics, daily activities, and special events via a choice of delivery channels.

About CTNM Contineum Therapeutics Inc.

Contineum Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of oral small-molecule therapies for neurological, inflammatory, and immunological conditions. The company focuses on developing selective compounds targeting challenging molecular pathways and has built a portfolio of small molecule drug candidates. Its pipeline includes drug candidates in clinical development, such as PIPE-791, an LPA1 receptor antagonist being studied for idiopathic pulmonary fibrosis and chronic pain, and PIPE-307, an M1 receptor inhibitor being evaluated for relapsing-remitting multiple sclerosis and other depressive disorders.

Share on Social Networks: